Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025)
Siga Technologies' (SIGA) quarterly Cash from Investing Activities came in at -$289576.0 in Q3 2025, down 1191.19% YoY from $26537.5 in Q3 2024, and down 28957500.0% on a QoQ basis from -$1.0 in Q2 2025.
Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 15 years of Cash from Investing Activities data on file, last reported at -$289576.0 in Q3 2025.
- Quarterly Cash from Investing Activities fell 1191.19% year-over-year to -$289576.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$332308.0 (down 1250.19% YoY) and the FY2024 annual result came in at -$42450.0, down 95.75% from the prior year.
- Cash from Investing Activities eased to -$289576.0 in Q3 2025, from -$1.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1.0 in Q2 2025 to a low of -$289576.0 in Q3 2025.
- A 4-year average of -$42922.6 and a median of -$19762.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 99.95% in 2025, down 1191.19% in 2025.
- Tracing SIGA's Cash from Investing Activities over 4 years: stood at -$26196.0 in 2021, then gained by 17.22% to -$21686.0 in 2023, then climbed by 17.74% to -$17838.0 in 2024, then slumped by 1523.37% to -$289576.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$289576.0 (Q3 2025), -$1.0 (Q2 2025), and -$24893.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -289,576.00 |
| Sep 30, 2025 | -289,576.00 |
| Jun 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -24,893.00 |
| Mar 31, 2025 | -24,893.00 |
| Dec 31, 2024 | -17,838.00 |
| Dec 31, 2024 | -17,838.00 |
| Sep 30, 2024 | -22,427.00 |
| Sep 30, 2024 | -22,427.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2023 | -21,686.00 |
| Jun 30, 2023 | -21,686.00 |
| Dec 31, 2021 | -26,196.00 |
| Dec 31, 2021 | -26,196.00 |
| Jun 30, 2021 | -10,700.00 |
| Jun 30, 2021 | -10,700.00 |
| Mar 31, 2021 | -13,724.00 |
| Mar 31, 2021 | -13,724.00 |